Clinical efficacy of Tailin formulation combined with continuous low-dose antimicrobial therapy for recurrent urinary tract infection: study protocol for a multicenter, double-blind, randomized, controlled clinical trial

Peer Review reports

Original Submission
22 Jul 2021	Submitted	Original manuscript
12 Sep 2021	Reviewed	Reviewer Report - Mateus Dias Antunes
17 Sep 2021	Reviewed	Reviewer Report - Alexander Gough
23 Oct 2021	Author responded	Author comments - Xuezhong Gong
Resubmission - Version 2
23 Oct 2021	Submitted	Manuscript version 2
2 Nov 2021	Reviewed	Reviewer Report - Alexander Gough
7 Nov 2021	Author responded	Author comments - Xuezhong Gong
Resubmission - Version 3
7 Nov 2021	Submitted	Manuscript version 3
12 Nov 2021	Reviewed	Reviewer Report - Alexander Gough
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
15 Nov 2021	Editorially accepted
11 Dec 2021	Article published	10.1186/s13063-021-05830-4

Back to article page